Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients in Real Life Condition in Czech Republic (UFO)

NCT01327001 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01327001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients in Real Life Condition in Czech Republic (UFO)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
June 30, 2011
Enrollment
2,815 (actual)
Sites
100

Conditions

As the registry lists them; a condition with its own page is linked.

asthma